Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Statistics in Medicine|October 18, 2024
Phase I/II Design for Selecting Subgroup-Specific Optimal Biological Doses for Prespecified SubgroupsSydney Porter, Thomas A Murray, Anne EatonStatistical Methods in Medical Research|April 1, 2025
Dose selection criteria to identify the optimal dose based on ranked efficacy-toxicity outcomes without reliance on clinical utilitiesSydney Porter, Anne Eaton, Thomas A MurrayClinical Trials (London, England)|August 8, 2024
Statistical approaches for component-wise censored composite endpointsAnne EatonNursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 23, 2016
Taken further to task over NVQsAnne EatonPharmaceutical Statistics|March 19, 2021
Logistic retainment interval dose exploration design for Phase I clinical trials of cytotoxic agentsThomas A MurrayBiometrics|June 13, 2020
Batch Bayesian optimization design for optimizing a neurostimulatorAdam Kaplan, Thomas A MurrayClinical Trials (London, England)|February 18, 2020
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerationsAnne Eaton, Terry Therneau, Jennifer Le-RademacherBiometrics|April 8, 2022
An alternative metric for evaluating the potential patient benefit of response-adaptive randomization proceduresJennifer Proper, Thomas A MurrayAnnals of Surgical Oncology|June 19, 2015
A Prospective Validation Study of Bioimpedance with Volume Displacement in Early-Stage Breast Cancer Patients at Risk for LymphedemaAndrea V Barrio, Anne Eaton, Thomas G FrazierBiometrics|April 29, 2021
Nonparametric estimation in an illness-death model with component-wise censoringAnne Eaton, Yifei Sun, James Neaton, et al.Pageof 14